Ajovy is one of the CGRP inhibitors used for migraine prevention. Approved for ages 6 and up, it's noted for its safety, tolerability, and benefits seen within the first month.

Okay. Good Afternoon, everybody. My name is Daniel Cohen. I'm a Managing Director in Morgan Stanley. For important disclosures, please see the Morgan Stanley research ...

Good morning, everyone. Thank you very much for carving out time this morning to attend the Morgan Stanley Healthcare Conference. My name is Ryuk Byun. I'm a Managing Director at Morgan Stanley ...

ANI Pharmaceuticals projects 33% to 37% revenue growth for 2025, driven by rare diseases. Purified Cortrophin Gel is a key growth driver, with expected multi-year potential. The company remains ...

In this innovative DIY tutorial, learn how to make a powerful air compressor at home using a simple syringe. This ...

Instead of stabbing yourself, or someone else, in the thigh with a needle to deliver a dose of adrenaline to counter ...

In the beginning of my career as a Clinical Laboratory Technologist one of my duties was providing phlebotomy services. It ...

A new systematic review shows that nasal spray adrenaline can be as fast or faster than injections for treating anaphylaxis ...

The nasal spray flu vaccine FluMist (LAIV) containing a weakened live flu virus that protects, will be launched as a first in Australia by the Minns Labor Government ahead of the April-October flu ...

JAMP Pharma Group launches PrPexegra®, a biosimilar alternative to the reference product PrNeulasta® (commercialized in ...

Analysts expect momentum to remain robust through 2025 and 2026, driven by the approval of the prefilled syringe format, expanding biologics use in gMG, and further CIDP uptake. Multiple Phase 3 ...